Is an AST (Aspartate Aminotransferase) level of 174 U/L considered high?

Yes, an AST of 174 U/L is significantly elevated and requires immediate evaluation to determine the underlying cause and assess for potential serious liver or non-liver injury.

An AST level of 174 U/L is approximately 4-5 times the upper limit of normal and falls into the "mild" elevation category (defined as <5 times ULN), though it approaches the moderate range and warrants thorough investigation 1.

Understanding the Elevation

Normal Reference Ranges

The upper limit of normal (ULN) for AST is generally considered 40 U/L in most laboratories, though some guidelines suggest lower sex-specific thresholds (32 U/L for men, 26 U/L for women in Korean populations) 2. Your level of 174 U/L represents approximately 4.4 times the conventional ULN.

Classification of Severity

According to current guidelines, aminotransferase elevations are classified as 1:

• Mild: <5 times ULN (your level falls here at ~4.4x)
• Moderate: 5-10 times ULN
• Severe: >10 times ULN

Critical Next Steps

Immediate Considerations

You must determine whether this is hepatocellular injury versus non-hepatic causes, as AST can be elevated from disorders involving the heart, skeletal muscle, kidneys, brain, and red blood cells—not just the liver 1.

Essential Companion Tests Needed

1. ALT level - This is critical for interpretation:

   • If ALT is also elevated and similar to AST: suggests hepatocellular injury
   • If AST is predominantly elevated with lower ALT: consider non-hepatic causes (hemolysis, myopathy, thyroid disease, exercise, cardiac injury) 1
   • AST:ALT ratio >2: suggests alcohol-induced liver disease 1
   • AST:ALT ratio <1: suggests metabolic/NAFLD 1

2. Alkaline phosphatase (ALP) and bilirubin:

   • If aminotransferases elevated much higher than ALP: hepatocellular pattern
   • If ALP elevated ≥2x ULN with or without bilirubin: cholestatic pattern 1

3. Additional markers to assess severity:

   • INR/prothrombin time
   • Albumin
   • Total and direct bilirubin
   • These indicate actual hepatic synthetic function and injury severity 1

Common Causes at This Level

Hepatic Causes (if ALT also elevated):

• Nonalcoholic fatty liver disease (NAFLD) - most common in developed countries (20-30% general population, 70% with obesity, 90% with diabetes) 1
• Alcohol-induced liver disease
• Viral hepatitis (B, C, A, E)
• Drug-induced liver injury
• Autoimmune hepatitis
• Hemochromatosis
• Ischemic hepatitis
• Acute Budd-Chiari syndrome 1

Non-Hepatic Causes (if AST disproportionately elevated):

• Skeletal muscle damage (most common non-hepatic cause at 54.2% of cases with markedly elevated AST) 3
• Cardiac muscle damage (39.1% of non-hepatic cases) 3
• Hemolysis
• Strenuous exercise
• Thyroid disease 1

Prognostic Significance

The magnitude of AST elevation correlates with outcomes in non-hepatic causes: In patients with AST >400 U/L from non-hepatic causes, 30-day mortality was 12.8% for peak AST <1000 U/L, 26.7% for <3000 U/L, and 50% for ≥3000 U/L 3. While your level of 174 U/L is below these thresholds, it still requires investigation.

Recommended Evaluation Algorithm

Core Laboratory Panel 4:

• Hepatitis B surface antigen (HBsAg)
• Hepatitis C antibody (then PCR if positive)
• Autoimmune markers (ANA, ASMA, IgG levels)
• Anti-mitochondrial antibody
• Ferritin and transferrin saturation
• Fasting glucose and lipid panel
• Creatine kinase (CK) to assess for muscle injury

Clinical History Focus 4:

• Alcohol intake (quantify units/week)
• Medications (prescribed, over-the-counter, herbal, supplements)
• Risk factors for metabolic syndrome (obesity, diabetes, hypertension)
• Recent strenuous exercise or muscle injury
• Cardiac symptoms
• Risk factors for viral hepatitis

Imaging:

Abdominal ultrasound is the appropriate first-line imaging for mild aminotransferase elevations to assess for steatosis, cirrhosis, or biliary abnormalities 1. It has 84.8% sensitivity and 93.6% specificity for moderate-severe hepatic steatosis (>30% fat content) 1.

Key Pitfalls to Avoid

1. Don't assume it's liver disease without checking ALT - AST can be elevated from multiple non-hepatic sources 1

2. Don't ignore metabolic risk factors - NAFLD is the most common cause of mild aminotransferase elevation in developed countries 1

3. Don't delay evaluation if accompanied by elevated bilirubin - ALT/AST ≥3x ULN with total bilirubin >2x ULN indicates more severe hepatocellular injury requiring urgent evaluation 5

4. Consider macro-AST - Rarely, immunoglobulin-AST complexes can cause persistently elevated AST with low ALT; this can be tested with polyethylene glycol precipitation if other causes are excluded 6